Revenue grew 26.2% year over year to $75.8M in 2026Q3 with gross margin near 74.8%, yet operating margin of only 1.3% and net margin of 3.1% indicate that SG&A spending of $46.8M still absorbs most of the gross profit.
AxoGen, Inc. (AXGN) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 | Jun'96 |
|---|
| Sales/Revenue | 266.93M | 225.21M | 187.34M | 159.01M | 138.58M | 127.36M | 112.3M | 106.71M | 83.94M | 60.43M | 41.11M | 27.33M | 16.82M | 10.95M | 7.69M | 4.85M | 91.27K | 24.91M | 72.71K | 100.43K | 126.66K | 443.35K | 1.06M | 7.24M | 6.85M | 15.93M | 14.6M | 12.3M | 12.9M | 12.3M | 13.1M |
| Revenue Growth % | 24.32% | 20.21% | 17.81% | 14.74% | 8.81% | 13.41% | 5.24% | 27.13% | 38.91% | 47% | 50.41% | 62.52% | 53.62% | 42.33% | 58.61% | 5213.15% | -99.63% | 34160.81% | -27.6% | -20.71% | -71.43% | -58.37% | -85.28% | 5.62% | -56.98% | 9.13% | 18.67% | -4.65% | 4.88% | -6.11% | -7.09% |
| Cost of Goods Sold | 68.92M | 57.85M | 45.36M | 37.14M | 29.77M | 22.93M | 21.58M | 17.35M | 12.92M | 9.31M | 6.47M | 4.85M | 3.44M | 2.44M | 1.96M | 2.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.5M | 5.21M | 10.51M | 8.57M | 7.3M | 8.4M | 6.9M | 7M |
| COGS % of Revenue | - | 25.69% | 24.21% | 23.36% | 21.49% | 18.01% | 19.22% | 16.26% | 15.4% | 15.41% | 15.73% | 17.74% | 20.47% | 22.29% | 25.51% | 50.04% | - | - | - | - | - | - | - | 75.93% | 76.07% | 65.96% | 58.69% | 59.35% | 65.12% | 56.1% | 53.44% |
| Gross Profit | 198M | 167.35M | 141.98M | 121.87M | 108.81M | 104.43M | 90.72M | 89.36M | 71.01M | 51.11M | 34.64M | 22.48M | 13.38M | 8.51M | 5.73M | 2.42M | 91.27K | 24.91M | 72.71K | 100.43K | 126.66K | 443.35K | 1.06M | 1.74M | 1.64M | 5.42M | 6.03M | 5M | 4.5M | 5.4M | 6.1M |
| Gross Margin % | 74.18% | 74.31% | 75.79% | 76.64% | 78.51% | 81.99% | 80.78% | 83.74% | 84.6% | 84.59% | 84.27% | 82.26% | 79.53% | 77.71% | 74.49% | 49.96% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 24.07% | 23.93% | 34.04% | 41.31% | 40.65% | 34.88% | 43.9% | 46.56% |
| Gross Profit Growth % | - | 17.87% | 16.5% | 12% | 4.2% | 15.11% | 1.52% | 25.84% | 38.93% | 47.56% | 54.08% | 68.09% | 57.22% | 48.48% | 136.48% | 2554.59% | -99.63% | 34160.81% | -27.6% | -20.71% | -71.43% | -58.37% | -38.85% | 6.22% | -69.76% | -10.06% | 20.58% | 11.11% | -16.67% | -11.48% | -7.58% |
| Operating Expenses | 211.81M | 175.2M | 145.26M | 143.33M | 138.52M | 129.84M | 113.9M | 120.77M | 91.51M | 59.07M | 42.77M | 31.75M | 23.18M | 18.1M | 13.53M | 9.39M | 1.94M | 8.96M | 1.13M | 900.35K | 524.04K | 769.87K | 1.19M | 2.99M | 4.13M | 8.43M | 8.92M | 6.8M | 4.9M | 5.3M | 6.7M |
| OpEx % of Revenue | - | 77.8% | 77.54% | 90.14% | 99.95% | 101.95% | 101.43% | 113.17% | 109.03% | 97.75% | 104.04% | 116.17% | 137.81% | 165.33% | 175.93% | 193.66% | 2125.27% | 35.95% | 1553.41% | 896.49% | 413.74% | 173.65% | 111.7% | 41.27% | 60.3% | 52.95% | 61.11% | 55.28% | 37.98% | 43.09% | 51.14% |
| Selling, General & Admin | 174.38M | 142.32M | 117.5M | 115.99M | 112.89M | 105.67M | 96.06M | 103.25M | 79.74M | 52.37M | 38.56M | 28.51M | 20.14M | 15.97M | 12.1M | 8.69M | 0 | 0 | 0 | 900.35K | 524.04K | 769.87K | 1.19M | 2.51M | 3.64M | 7.33M | 6.92M | 4.7M | 3.1M | 2.8M | 3.7M |
| SG&A % of Revenue | - | 63.19% | 62.72% | 72.95% | 81.46% | 82.97% | 85.53% | 96.76% | 95% | 86.66% | 93.8% | 104.32% | 119.77% | 145.92% | 157.37% | 179.28% | - | - | - | 896.49% | 413.74% | 173.65% | 111.7% | 34.68% | 53.12% | 46.05% | 47.39% | 38.21% | 24.03% | 22.76% | 28.24% |
| Research & Development | 37.43M | 32.88M | 27.77M | 27.34M | 25.63M | 24.18M | 17.85M | 17.51M | 11.77M | 6.7M | 4.21M | 3.24M | 3.03M | 2.13M | 1.43M | 697.36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 424.46K | 491.51K | 919.79K | 1.09M | 1.2M | 1M | 1.5M | 1.9M |
| R&D % of Revenue | - | 14.6% | 14.82% | 17.19% | 18.49% | 18.98% | 15.89% | 16.41% | 14.03% | 11.09% | 10.25% | 11.84% | 18.04% | 19.42% | 18.56% | 14.38% | - | - | - | - | - | - | - | 5.87% | 7.17% | 5.77% | 7.5% | 9.76% | 7.75% | 12.2% | 14.5% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28K | -30.77K | -19.63K | 26.82K | 3.15K | 33.89K | 23.97K | 0 | 1.94M | 8.96M | 1.13M | 0 | 0 | 0 | 0 | 52.38K | 0 | 180K | 908.02K | 900K | 800K | 1M | 1.1M |
| Operating Income | -13.8M | -7.85M | -3.29M | -21.46M | -29.71M | -25.42M | -23.18M | -31.41M | -20.5M | -7.95M | -8.13M | -9.27M | -9.8M | -9.59M | -7.8M | -6.97M | -1.85M | 15.96M | -1.06M | -799.92K | -397.38K | -326.52K | -124.6K | -1.25M | -2.49M | -3.32M | -2.89M | -1.8M | -400K | 100K | -600K |
| Operating Margin % | -5.17% | -3.49% | -1.75% | -13.5% | -21.44% | -19.96% | -20.64% | -29.43% | -24.42% | -13.16% | -19.78% | -33.91% | -58.28% | -87.62% | -101.43% | -143.7% | -2025.27% | 64.05% | -1453.41% | -796.49% | -313.74% | -73.65% | -11.7% | -17.21% | -36.37% | -20.82% | -19.8% | -14.63% | -3.1% | 0.81% | -4.58% |
| Operating Income Growth % | - | -138.79% | 84.68% | 27.75% | -16.88% | -9.64% | 26.19% | -53.2% | -157.82% | 2.2% | 12.27% | 5.45% | -2.17% | -22.95% | -11.96% | -276.99% | -111.59% | 1609.83% | -32.11% | -101.3% | -21.7% | -162.05% | 89.99% | 50.03% | 24.84% | -14.71% | -60.58% | -350% | -500% | 116.67% | -500% |
| EBITDA | -4.89M | 344K | 4.55M | -15.91M | -24.85M | -20.68M | -19.72M | -28.53M | -19.65M | -7.38M | -7.69M | -9.02M | -9.6M | -9.45M | -7.49M | -6.63M | -1.83M | 15.98M | -1.03M | -777.65K | -371.92K | -306.48K | 87.68K | -721.89K | -1.87M | -2.79M | -1.98M | -900K | 400K | 1.1M | 500K |
| EBITDA Margin % | -1.83% | 0.15% | 2.43% | -10% | -17.93% | -16.23% | -17.56% | -26.73% | -23.41% | -12.22% | -18.72% | -32.99% | -57.09% | -86.36% | -97.34% | -136.68% | -2003.61% | 64.14% | -1421.61% | -774.31% | -293.63% | -69.13% | 8.23% | -9.98% | -27.24% | -17.54% | -13.58% | -7.32% | 3.1% | 8.94% | 3.82% |
| EBITDA Growth % | -142.95% | -92.44% | 128.6% | 35.99% | -20.21% | -4.83% | 30.87% | -45.19% | -166.08% | 4.01% | 14.69% | 6.08% | -1.57% | -26.27% | -12.96% | -262.43% | -111.44% | 1645.84% | -32.92% | -109.09% | -21.35% | -449.53% | 112.15% | 61.33% | 33.2% | -40.95% | -120.27% | -325% | -63.64% | 120% | -37.5% |
| D&A (Non-Cash Add-back) | 8.91M | 8.19M | 7.84M | 5.55M | 4.85M | 4.74M | 3.46M | 2.88M | 851K | 566.6K | 436.49K | 248.97K | 198.89K | 138.33K | 314.83K | 340.68K | 19.77K | 23.01K | 23.12K | 22.27K | 25.46K | 20.04K | 212.28K | 523.27K | 625.14K | 521.28K | 908.02K | 900K | 800K | 1M | 1.1M |
| EBIT | -30.15M | -8M | -1.76M | -18.88M | -28.32M | -25.63M | -22.73M | -29.09M | -21.19M | -7.98M | -8.15M | -9.24M | -9.8M | -9.56M | -7.78M | -6.9M | -4.48M | 15.96M | -1.06M | -799.92K | -397.38K | -326.52K | -124.6K | -1.62M | -2.49M | -7.72M | -3.01M | -2.89M | -1.8M | -400K | 100K |
| Net Interest Income | -197K | -7.7M | -8.21M | -2.83M | -624K | -1.36M | -1.05M | -40K | -1.21M | -2.46M | -6.26M | -4.12M | -7.91M | -5M | -2.38M | -2.32M | -2.14M | 1.95K | 16.08K | 0 | 61.85K | 0 | 0 | -37.79K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 2.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.95K | 16.08K | 0 | 61.85K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.41M | 7.7M | 8.21M | 2.83M | 624K | 1.36M | 1.05M | 40K | 1.21M | 2.46M | 6.26M | 4.12M | 7.91M | 5M | 2.38M | 2.32M | 2.14M | 0 | 0 | 0 | 0 | 0 | 0 | 37.79K | 131.08K | -8.78M | 0 | 0 | 0 | 2.2M | 0 |
| Other Income/Expense | -18.12M | -7.85M | -6.68M | -254K | 759K | -1.57M | -604K | 2.27M | -1.9M | -2.49M | -6.28M | -4.09M | -7.91M | -4.96M | -2.35M | -2.25M | 2.66M | 1.95K | 16.08K | 50.94K | 61.85K | 0 | 0 | -370.27K | -136.38K | 4.71M | 4.28M | -7.71K | 1.4M | 500K | 0 |
| Pretax Income | -31.92M | -15.7M | -9.96M | -21.72M | -28.95M | -26.98M | -23.79M | -29.14M | -22.4M | -10.45M | -14.41M | -13.36M | -17.71M | -14.56M | -10.16M | -6.9M | -1.83M | 15.96M | 0 | 0 | 0 | -326.52K | -124.6K | -1.28M | -2.63M | 1.39M | -2.9M | -1.7M | -400K | 100K | -600K |
| Pretax Margin % | -11.96% | -6.97% | -5.32% | -13.66% | -20.89% | -21.19% | -21.18% | -27.3% | -26.68% | -17.29% | -35.06% | -48.87% | -105.31% | -132.97% | -132.04% | -142.31% | -1999.88% | 64.06% | - | - | - | -73.65% | -11.7% | -17.67% | -38.36% | 8.74% | -19.86% | -13.82% | -3.1% | 0.81% | -4.58% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.49M | 0 | 0 | 0 | 0 | -738.19K | -134.58K | -509.05K | 1.04M | -16.08K | -50.94K | -30.2K | 0 | -1.45K | 3K | -25.47K | 48K | -38.93K | -200K | -100K | 4.6M | -100K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -23.88% | 0% | 0% | 0% | 0% | 7.27% | 1.95% | 27.89% | 6.53% | - | - | - | 0% | 1.16% | -0.23% | 0.97% | 3.45% | 1.34% | 11.76% | 25% | 4600% | 16.67% |
| Net Income | -31.92M | -15.7M | -9.96M | -21.72M | -28.95M | -26.98M | -23.79M | -29.12M | -22.4M | -10.45M | -14.41M | -13.36M | -17.71M | -14.56M | -9.42M | -9.22M | -1.32M | 15.05M | -1.04M | -748.98K | -367.18K | -530.61K | 2.3M | -1.28M | -2.6M | 1.34M | -2.86M | -1.7M | -400K | -2.3M | -600K |
| Net Margin % | -11.96% | -6.97% | -5.32% | -13.66% | -20.89% | -21.19% | -21.18% | -27.29% | -26.68% | -17.29% | -35.06% | -48.87% | -105.31% | -132.97% | -122.44% | -190.11% | -1442.16% | 60.4% | -1431.3% | -745.77% | -289.9% | -119.68% | 215.65% | -17.71% | -37.99% | 8.43% | -19.59% | -13.82% | -3.1% | -18.7% | -4.58% |
| Net Income Growth % | -1422.27% | -57.6% | 54.12% | 24.98% | -7.27% | -13.45% | 18.32% | -30.03% | -114.42% | 27.52% | -7.9% | 24.58% | -21.66% | -54.57% | -2.16% | -600.39% | -108.75% | 1545.78% | -38.95% | -103.98% | 30.8% | -123.1% | 279.18% | 50.75% | -293.73% | 146.99% | -68.19% | -325% | 82.61% | -283.33% | -400% |
| Net Income (Continuing) | -31.92M | -15.7M | -9.96M | -21.72M | -28.95M | -26.98M | -23.79M | -29.14M | -22.4M | -10.45M | -14.41M | -13.36M | -17.71M | -14.56M | -9.42M | -9.22M | -1.32M | 14.92M | -1.04M | -748.98K | -335.53K | -326.52K | -123.15K | -1.62M | -2.6M | 1.34M | 1.34M | -2.86M | -1.7M | -400K | -2.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.52 | -0.34 | -0.23 | -0.51 | -0.69 | -0.65 | -0.60 | -0.74 | -0.60 | -0.31 | -0.47 | -0.51 | -1.00 | -1.08 | -0.85 | -2.49 | -0.31 | 3.49 | -0.24 | -0.18 | -0.09 | -0.13 | 0.57 | -0.32 | -0.66 | 0.34 | -0.74 | -0.43 | -0.10 | -0.60 | -0.16 |
| EPS Growth % | -1229.24% | -47.83% | 54.9% | 26.09% | -6.15% | -8.33% | 18.92% | -23.33% | -93.55% | 34.04% | 7.84% | 49% | 7.41% | -27.06% | 65.86% | -703.23% | -108.88% | 1554.17% | -33.33% | -103.39% | 31.92% | -122.81% | 278.13% | 51.52% | -294.12% | 145.95% | -72.09% | -330.43% | 83.35% | -275% | -405.93% |
| EPS (Basic) | - | -0.34 | -0.23 | -0.51 | -0.69 | -0.65 | -0.60 | -0.74 | -0.60 | -0.31 | -0.47 | -0.51 | -1.00 | -1.08 | -0.85 | -2.49 | -0.31 | 3.51 | -0.24 | -0.18 | -0.09 | -0.13 | 0.57 | -0.32 | -0.66 | 0.34 | -0.74 | -0.43 | -0.10 | -0.60 | -0.16 |
| Diluted Shares Outstanding | 61.53M | 46.05M | 44.26M | 42.88M | 42.08M | 41.22M | 39.97M | 39.23M | 37.13M | 33.32M | 30.7M | 26.08M | 17.72M | 13.5M | 11.09M | 3.7M | 4.31M | 4.31M | 4.27M | 4.17M | 4.15M | 4.13M | 4.12M | 3.97M | 3.96M | 3.93M | 3.89M | 3.95M | 4.01M | 3.86M | 3.8M |
| Basic Shares Outstanding | 55.16M | 46.05M | 44.26M | 42.88M | 42.08M | 41.22M | 39.97M | 39.23M | 37.13M | 33.32M | 30.7M | 26.08M | 17.72M | 13.5M | 11.09M | 3.7M | 4.31M | 4.29M | 4.27M | 4.17M | 4.15M | 4.13M | 4.01M | 3.97M | 3.96M | 3.91M | 3.89M | 3.95M | 4.01M | 3.84M | 3.8M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying AXGN stock.
For fiscal year 2025, AxoGen, Inc. (AXGN) reported total revenue of $225.2M. This represents a 1619.1% increase compared to $13.1M in 1996.
AxoGen, Inc. (AXGN) reported a net loss of $15.7M for the fiscal year ending 2025.
AxoGen, Inc. (AXGN) reported an operating income of $-7.8M, resulting in an operating profit margin of -3.5%. This margin reflects the operational efficiency of the business before interest and taxes.
AxoGen, Inc. (AXGN) generated $167.4M in gross profit for the year, representing a gross profit margin of 74.3%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Persistent operating losses
Metrics are mathematically derived from official filings.
Top-Line Growth Holds Near Twenty Percent
According to reported quarterly figures, AXGN's revenue reached $75.8M in 2026Q3, up 26.2% year over year, with growth sustained at 23.1% to 26.6% across the most recent three quarters, suggesting durable commercial momentum.
The consistency of growth across quarters suggests demand is being driven by expanding surgical account penetration rather than a single lumpy event. Investors should note that the revenue base is still small relative to the company's cost structure, so sustaining this rate will be essential to justify the current valuation. Whether this growth reflects volume or pricing is not separable from the reported data and warrants further investigation.
Gross Margin Anchored Near Seventy-Five Percent
Based on reported figures, AXGN's gross margin has held between 71.9% and 76.6% over ten quarters, with the most recent quarter at 74.8%, indicating that the proprietary processing advantage appears structurally intact despite volume scaling.
A stable high gross margin implies the company retains meaningful pricing power and that tissue recovery yields have not deteriorated materially as volumes grew. The quarterly swings, particularly the dip to 71.9% in 2025Q1, may reflect transitional manufacturing variances rather than a structural shift. Margin durability at this level is a key pillar of the investment case, and any sustained compression would merit close scrutiny.
Operating Leverage Remains Elusive
As reported in financial statements, AXGN's operating margin moved from -16.3% in 2025Q4 to just 1.3% in 2026Q3, but remained negative in three of the last four quarters, indicating that gross profit gains are not yet translating into consistent operating leverage.
SG&A has grown roughly in line with gross profit, which suggests the commercial infrastructure is being expanded to support growth rather than absorbing it efficiently. The positive operating result in the latest quarter is encouraging but appears to be a single data point that may not yet reflect a structural inflection. Investors should monitor whether SG&A as a percentage of revenue declines meaningfully in the coming quarters.
Net Income Volatility Obscures Underlying Trend
Based on EDBL's reported figures, AXGN's net income swung from a $19.6M loss in 2026Q1 to a $2.3M profit in 2026Q3, with EPS growth figures distorted by near-zero prior-period bases, limiting the reliability of year-over-year earnings comparisons.
The magnitude of the 2026Q1 net loss relative to its operating loss suggests non-operating or tax-related items may have contributed, though the data alone cannot confirm this. Stock-based compensation of $6.8M to $16.6M per quarter is a significant reconciling item and may mask the economic cash cost of operations. Earnings quality is therefore best assessed on operating income and cash flow rather than headline EPS.
Growth Without Profit Raises Dilution Questions
According to recent SEC filings, AXGN has reported negative operating margins in most recent quarters while growing revenue above 20%, and the bear case would question whether this growth is being bought with heavy SG&A spending and stock-based compensation.
If operating losses persist while SBC remains elevated, the company may continue relying on equity or external capital to fund operations, a scenario the reported income statement alone cannot rule out. Short-sellers would likely argue that the recent positive quarter reflects timing rather than durable leverage. Investors should monitor whether the company can sustain profitability without material reliance on non-operating support.